Feedback / Questions
KLN-1010 - Kelonia Therap
https://www.businesswire.com/news/home/20251209935959/en/Kelonia-Therapeutics-Presents-First-in-Human-Data-From-Phase-1-inMMyCAR-Study-of-KLN-1010-in-vivo-BCMA-CAR-T-Therapy-at-the-American-Society-of-Hematology-ASH-2025-Annual-Meeting
Dec 9, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next